Markus W Büchler

12PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Deep learningPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Feb 12, 2026
Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Faik G Uzunoglu, Christoph Springfeld, Teresa Peccerella

|Feb 04, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial.

Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova

|Aug 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.

Nan Wei, René Michael Mathy, De-Hua Chang

|Mar 31, 2025
Reply to: Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4.

Daniel H Palmer, Richard J Jackson, Christoph Springfeld

|Dec 05, 2024
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.

Daniel H Palmer, Richard Jackson, Christoph Springfeld

Pageof 2

Frequent Collaborators

7 joint publications

John P Neoptolemos

3 joint publications

Peter Bailey

3 joint publications

Christoph W Michalski

2 joint publications

Teresa Peccerella